CYBERMED LIFE - ORGANIC  & NATURAL LIVING

Laughter-Humor

Laughter therapy modulates the parameters of renin-angiotensin system in patients with type 2 diabetes.

Written by CYBERMED LIFE NEWS
facebook Share on Facebook
Abstract Title:

Laughter therapy modulates the parameters of renin-angiotensin system in patients with type 2 diabetes.

Abstract Source:

Int J Mol Med. 2005 Dec;16(6):1077-81. PMID: 16273289

Abstract Author(s):

Uddin Mohammad Nasir, Shizuko Iwanaga, A H M Nurun Nabi, Osamu Urayama, Keiko Hayashi, Takashi Hayashi, Koichi Kawai, Afroza Sultana, Kazuo Murakami, Fumiaki Suzuki

Abstract:

The effect of laughter therapy on the plasma levels of renin, angiotensinogen, and prorenin was investigated in patients with type 2 diabetes. In the diabetic patients, the mean plasma renin concentrations were 24.6+/-12.1 ng/ml/h in the first observation (at the beginning of laughter therapy), 8.2+/-3.4 ng/ml/h in the second observation (three months after the beginning of laughter therapy) and 7.7+/-1.7 ng/ml/h in the third observation (six months after the beginning of laughter therapy). The mean plasma angiotensinogen concentrations in the 1st, 2nd and 3rd observations were 0.19+/-0.08, 0.47+/-0.12, 0.42+/-0.14 microg/ml, respectively. The mean plasma prorenin concentrations in the 1st, 2nd and 3rd observations during the laughter therapy were 195.1+/-66.2, 193.4+/-88.2 and 170.7+/-52.5 pg/ml, respectively. Plasma renin concentrations were significantly decreased (p<0.05) by the therapy. Subnormal concentrations of plasma angiotensinogen were found in the 1st observation and increased significantly (p<0.05) to the normal range after the therapy. Plasma prorenin concentration only slightly changed during the laughter therapy. Other biochemical parameters remained unchanged during the laughter therapy. These results indicated that a long-term laughter therapy changed the plasma components of renin-angiotensin system in patients with diabetes. Thus, laughter therapy can be used as non-pharmacological treatment for the prevention of diabetic microvascular complications.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.